Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women
Authors:
- Christine L CookCCChristine L Cook
- Yong SiowYSYong Siow
- Amy G BrennerABAmy G Brenner
- Mary E FallatMFMary E Fallat
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (1) , 141-146
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Polycystic ovaries and associated clinical and biochemical features in young womenClinical Endocrinology, 1999
- Diagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell TumorsGynecologic Oncology, 1999
- Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalitiesJournal of Pediatric Surgery, 1993
- Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord TumorNew England Journal of Medicine, 1992
- Treatment with dexamethasone of androgen excess in adolescent patientsThe Journal of Pediatrics, 1988
- Immunocytochemical study of anti-Müllerian hormone in sheep ovarian follicles during fetal and post-natal developmentReproduction, 1987
- Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndromeThe Journal of Pediatrics, 1983
- FURTHER OBSERVATIONS ON THE DEFECTIVE SYNTHESIS OF OVARIAN STEROIDS IN THE STEIN-LEVENTHAL SYNDROMEJournal of Endocrinology, 1962
- Defective Biosynthesis of Ovarian Steroids in the Stein-Leventhal SyndromeBMJ, 1961